Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Allergy Asthma Proc. 2010 Sep-Oct;31(5):375-80. doi: 10.2500/aap.2010.31.3329.

Allergic rhinitis: Direct and indirect costs.

Author information

  • Department of Pediatrics and Medicine, University of Tennessee Health Science Center, Memphis, 38120, USA. mblaiss@allergymemphis.com

Abstract

Allergic rhinitis is one of the most common conditions affecting both children and adults. Along with the burden of the disease and decrease in quality of life associated with allergic rhinitis, there are high costs related to the disorder. Costs due to allergic rhinitis can be divided into two categories: direct costs that are related to monies spent on the course of managing the disease and indirect costs that are due to missing work and decreased productivity due to the illness. There are also the costs associated with the comorbidities of allergic rhinitis, such as sinusitis and asthma, which are classified as "hidden" direct costs. Management of allergic rhinitis involves allergen avoidance, proper pharmacologic therapies, and allergen immunotherapy. These treatments add to the direct cost of the condition and need to be evaluated to determine their cost-effectiveness in the control of the patient's nasal allergies. This article reviews the latest data on cost issues in allergic rhinitis and information of cost-effectiveness of treatments for this condition.

PMID:
20929603
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ingenta plc
    Loading ...
    Write to the Help Desk